597 research outputs found
Does present use of cardiovascular medication reflect elevated cardiovascular risk scores estimated ten years ago? A population based longitudinal observational study
Background
It is desirable that those at highest risk of cardiovascular disease should have priority for preventive measures, eg. treatment with prescription drugs to modify their risk. We wanted to investigate to what extent present use of cardiovascular medication (CVM) correlates with cardiovascular risk estimated by three different risk scores (Framingham, SCORE and NORRISK) ten years ago.
Methods
Prospective logitudinal observational study of 20 252 participants in The Hordaland Health Study born 1950-57, not using CVM in 1997-99. Prescription data obtained from The Norwegian Prescription Database in 2008.
Results
26% of men and 22% of women aged 51-58 years had started to use some CVM during the previous decade. As a group, persons using CVM scored significantly higher on the risk algorithms Framingham, SCORE and NORRISK compared to those not treated. 16-20% of men and 20-22% of women with risk scores below the high-risk thresholds for the three risk scores were treated with CVM, while 60-65% of men and 25-45% of women with scores above the high-risk thresholds received no treatment. Among women using CVM, only 2.2% (NORRISK), 4.4% (SCORE) and 14.5% (Framingham) had risk scores above the high-risk values. Low education, poor self-reported general health, muscular pains, mental distress (in females only) and a family history of premature cardiovascular disease correlated with use of CVM. Elevated blood pressure was the single factor most strongly predictive of CVM treatment.
Conclusion
Prescription of CVM to middle-aged individuals by large seems to occur independently of estimated total cardiovascular risk, and this applies especially to females
Patterns of analgesic use, pain and self-efficacy: a cross-sectional study of patients attending a hospital rheumatology clinic
Background: Many people attending rheumatology clinics use analgesics and non-steroidal anti-inflammatories for persistent musculoskeletal pain. Guidelines for pain management recommend regular and pre-emptive use of analgesics to reduce the impact of pain. Clinical experience indicates that analgesics are often not used in this way. Studies exploring use of analgesics in arthritis have historically measured adherence to such medication. Here we examine patterns of analgesic use and their relationships to pain, self-efficacy and demographic factors.
Methods: Consecutive patients were approached in a hospital rheumatology out-patient clinic. Pattern of analgesic use was assessed by response to statements such as 'I always take my tablets every day.' Pain and self-efficacy (SE) were measured using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and Arthritis Self-Efficacy Scale (ASES). Influence of factors on pain level and regularity of analgesic use were investigated using linear regression. Differences in pain between those agreeing and disagreeing with statements regarding analgesic use were assessed using t-tests.
Results: 218 patients (85% of attendees) completed the study. Six (2.8%) patients reported no current pain, 26 (12.3%) slight, 100 (47.4%) moderate, 62 (29.4%) severe and 17 (8.1%) extreme pain. In multiple linear regression self efficacy and regularity of analgesic use were significant (p < 0.01) with lower self efficacy and more regular use of analgesics associated with more pain.
Low SE was associated with greater pain: 40 (41.7%) people with low SE reported severe pain versus 22 (18.3%) people with high SE, p < 0.001. Patients in greater pain were significantly more likely to take analgesics regularly; 13 (77%) of those in extreme pain reported always taking their analgesics every day, versus 9 (35%) in slight pain. Many patients, including 46% of those in severe pain, adjusted analgesic use to current pain level. In simple linear regression, pain was the only variable significantly associated with regularity of analgesic use: higher levels of pain corresponded to more regular analgesic use (p = 0.003).
Conclusion: Our study confirms that there is a strong inverse relationship between self-efficacy and pain severity. Analgesics are often used irregularly by people with arthritis, including some reporting severe pain
Increasing Dominance - the Role of Advertising, Pricing and Product Design
Despite the empirical relevance of advertising strategies in concentrated markets, the economics literature is largely silent on the effect of persuasive advertising
strategies on pricing, market structure and increasing (or decreasing) dominance. In a simple model of persuasive advertising and pricing with differentiated goods,
we analyze the interdependencies between ex-ante asymmetries in consumer appeal, advertising and prices. Products with larger initial appeal to consumers will
be advertised more heavily but priced at a higher level - that is, advertising and price discounts are strategic substitutes for products with asymmetric initial appeal.
We find that the escalating effect of advertising dominates the moderating effect of pricing so that post-competition market shares are more asymmetric than pre-competition differences in consumer appeal. We further find that collusive advertising (but competitive pricing) generates the same market outcomes, and that network effects lead to even more extreme market outcomes, both directly and via
the effect on advertising
Incentive Compatible Reimbursement Schemes for Physicians
We consider physicians with fixed capacity levels. If a physician’s capacity exceeds demand, she may have an incentive to overtreat, i.e., she may provide unnecessary treatments to use up idle capacity. By contrast, with excess demand she may undertreat, i.e., she may not provide necessary treatments since other activities are financially more attractive. We first show that simple fee-for-service reimbursement schemes do not provide proper incentives.
If insurers use, however, fee-for-service schemes with quantity restrictions, they solve the fraudulent physician problem
Localization of the SFT inspired Nonlocal Linear Models and Exact Solutions
A general class of gravitational models driven by a nonlocal scalar field
with a linear or quadratic potential is considered. We study the action with an
arbitrary analytic function , which has both simple and double roots.
The way of localization of nonlocal Einstein equations is generalized on models
with linear potentials. Exact solutions in the Friedmann-Robertson-Walker and
Bianchi I metrics are presented.Comment: 20 pages, 3 figures, published in the proceedings of the VIII
International Workshop "Supersymmetries and Quantum Symmetries" (SQS'09),
Dubna, Russia, July 29 - August 3, 2009, http://theor.jinr.ru/~sqs09
Macdonald Polynomials from Sklyanin Algebras: A Conceptual Basis for the -Adics-Quantum Group Connection
We establish a previously conjectured connection between -adics and
quantum groups. We find in Sklyanin's two parameter elliptic quantum algebra
and its generalizations, the conceptual basis for the Macdonald polynomials,
which ``interpolate'' between the zonal spherical functions of related real and
\--adic symmetric spaces. The elliptic quantum algebras underlie the
\--Baxter models. We show that in the n \air \infty limit, the Jost
function for the scattering of {\em first} level excitations in the
\--Baxter model coincides with the Harish\--Chandra\--like \--function
constructed from the Macdonald polynomials associated to the root system .
The partition function of the \--Baxter model itself is also expressed in
terms of this Macdonald\--Harish\--Chandra\ \--function, albeit in a less
simple way. We relate the two parameters and of the Macdonald
polynomials to the anisotropy and modular parameters of the Baxter model. In
particular the \--adic ``regimes'' in the Macdonald polynomials correspond
to a discrete sequence of XXZ models. We also discuss the possibility of
``\--deforming'' Euler products.Comment: 25 page
Determinants of cardiac troponin T elevation in COPD exacerbation – a cross-sectional study
<p>Abstract</p> <p>Background</p> <p>Cardiac Troponin T (cTnT) elevation during exacerbations of chronic obstructive pulmonary disease (COPD) is associated with increased mortality the first year after hospital discharge. The factors associated with cTnT elevation in COPD are not known.</p> <p>Methods</p> <p>From our hospital's database, all patients admitted with COPD exacerbation in 2000–03 were identified. 441 had measurement of cTnT performed. Levels of cTnT ≥ 0.04 μg/l were considered elevated. Clinical and historical data were retrieved from patient records, hospital and laboratory databases. Odds ratios for cTnT elevation were calculated using logistic regression.</p> <p>Results</p> <p>120 patients (27%) had elevated cTnT levels. The covariates independently associated with elevated cTnT were increasing neutrophil count, creatinine concentration, heart rate and Cardiac Infarction Injury Score (CIIS), and decreasing hemoglobin concentration. The adjusted odds ratios (95% confidence intervals in parentheses) for cTnT elevation were 1.52 (1.20–1.94) for a 5 × 10<sup>6</sup>/ml increase in neutrophils, 1.21 (1.12–1.32) for a 10 μmol/l increase in creatinine, 0.80 (0.69–0.92) for a 1 mg/dl increase in hemoglobin, 1.24 (1.09–1.42) for a 10 beats/minute increase in heart rate and 1.44 (1.15–1.82) for a 10 point increase in CIIS.</p> <p>Conclusion</p> <p>Multiple factors are associated with cTnT elevation, probably reflecting the wide panorama of comorbid conditions typically seen in COPD. The positive association between neutrophils and cTnT elevation is compatible with the concept that an exaggerated inflammatory response in COPD exacerbation may predispose for myocardial injury.</p
The Interface Region Imaging Spectrograph (IRIS)
The Interface Region Imaging Spectrograph (IRIS) small explorer spacecraft
provides simultaneous spectra and images of the photosphere, chromosphere,
transition region, and corona with 0.33-0.4 arcsec spatial resolution, 2 s
temporal resolution and 1 km/s velocity resolution over a field-of-view of up
to 175 arcsec x 175 arcsec. IRIS was launched into a Sun-synchronous orbit on
27 June 2013 using a Pegasus-XL rocket and consists of a 19-cm UV telescope
that feeds a slit-based dual-bandpass imaging spectrograph. IRIS obtains
spectra in passbands from 1332-1358, 1389-1407 and 2783-2834 Angstrom including
bright spectral lines formed in the chromosphere (Mg II h 2803 Angstrom and Mg
II k 2796 Angstrom) and transition region (C II 1334/1335 Angstrom and Si IV
1394/1403 Angstrom). Slit-jaw images in four different passbands (C II 1330, Si
IV 1400, Mg II k 2796 and Mg II wing 2830 Angstrom) can be taken simultaneously
with spectral rasters that sample regions up to 130 arcsec x 175 arcsec at a
variety of spatial samplings (from 0.33 arcsec and up). IRIS is sensitive to
emission from plasma at temperatures between 5000 K and 10 MK and will advance
our understanding of the flow of mass and energy through an interface region,
formed by the chromosphere and transition region, between the photosphere and
corona. This highly structured and dynamic region not only acts as the conduit
of all mass and energy feeding into the corona and solar wind, it also requires
an order of magnitude more energy to heat than the corona and solar wind
combined. The IRIS investigation includes a strong numerical modeling component
based on advanced radiative-MHD codes to facilitate interpretation of
observations of this complex region. Approximately eight Gbytes of data (after
compression) are acquired by IRIS each day and made available for unrestricted
use within a few days of the observation.Comment: 53 pages, 15 figure
Pharmaceutical Cost-Sharing Systems and Savings for Health Care Systems from Parallel Trade
- …